Joseph Park

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index4.2kcitations122works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Associations and Epidemiology(14), Liver Disease Diagnosis and Treatment(12), Renal and related cancers(10), Lipoproteins and Cardiovascular Health(7), Neuroinflammation and Neurodegeneration Mechanisms(7)

Publications122 total

Abstract 4366989: Pathogenic variants in myoferlin ( <i>MYOF)</i> cause arrhythmogenic cardiomyopathy
Circulation·2025
1947P Phase II study of sacituzumab govitecan (SG), domvanalimab (dom), and zimberelimab (zim) in metastatic non-small cell lung cancer (mNSCLC): VELOCITY-Lung substudy-01
Annals of Oncology·2025
Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer’s disease
Science Translational Medicine·2025· 1 citedOpen Access
Novel Percutaneous Septectomy for Left Atrial Myxoma
JACC: Cardiovascular Interventions·2025
<i>Ppp1r3b</i> is a metabolic switch that shifts hepatic energy storage from lipid to glycogen
Science Advances·2025· 5 citedOpen Access
314 Assessing the pathogenicity of Staphylococcus aureus from diabetic foot ulcer infections in diabetic TALLYHO/JngJ mouse model
The American Journal of the Medical Sciences·2025
P1339 CJRB-201, a promising candidate for microbiome-based therapy with potent anti-inflammatory effects in Inflammatory Bowel Disease
Journal of Crohn s and Colitis·2025
Trends in incidence and complications of ankle arthrodesis and total ankle arthroplasty
International Journal of Research in Orthopaedics·2024Open Access
Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in <i>BAG3</i>
JAMA Cardiology·2024· 6 citedOpen Access
Development of Novel Peripheral Blood Count-Based Prognostic Index for Multiple Myeloma
Blood·2024Open Access
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma
Blood·2024Open Access
Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma
Blood Advances·2024· 4 citedOpen Access
Deep metabolic phenotyping of humans with protein-altering variants in TM6SF2 using a genome-first approach
JHEP Reports·2024· 6 citedOpen Access
PP01.112 Treatment Patterns and Outcomes in Second-Line Advanced NSCLC Treated After Prior Platinum Chemotherapy and Immunotherapy Combination Therapy: A Real-World Study
Journal of Thoracic Oncology·2024Open Access
The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD
Med·2024· 6 citedOpen Access
384 ASSOCIATION OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR GENE VARIANT WITH METABOLIC DYSFUNCTION ASSOCIATED LIVER DISEASE (MASLD)
Gastroenterology·2024
Infiltrating CD8+ T cells exacerbate Alzheimer's disease pathology in a novel 3D human neuroimmune axis model
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling
Neuron·2023· 85 citedOpen Access
Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model
Nature Neuroscience·2023· 169 citedOpen Access
A genome-first approach to identify carriers of familial hypercholesterolemia-causing variants
Atherosclerosis·2023Open Access
page 1 of 7Next →

Frequent Co-authors

Daniel J. Rader(16), Marylyn D. Ritchie(10), Yong‐Min Huh(10), Scott M. Damrauer(8), Seungjoo Haam(8), Aris Baras(7), Jin‐Suck Suh(7), Marijana Vujković(6), Carolin V. Schneider(6), Jaemoon Yang(6), Xiuqing Guo(5), Rachel L. Kember(5), Anurag Verma(5), Renae Judy(5), John D. Overton(5), Jeffrey G. Reid(5), Eun‐Kyung Lim(5), Jihye Choi(5), Rudolph E. Tanzi(4), Christopher D. Brown(4)